» Articles » PMID: 30865215

Burden of Cardiovascular Diseases in China, 1990-2016: Findings From the 2016 Global Burden of Disease Study

Overview
Journal JAMA Cardiol
Date 2019 Mar 14
PMID 30865215
Citations 299
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Cardiovascular disease (CVD) remains the top cause of death in China. To our knowledge, no consistent and comparable assessments of CVD burden have been produced at subnational levels, and little is understood about the spatial patterns and temporal trends of CVD in China.

Objective: To determine the national and province-level burden of CVD from 1990 to 2016 in China.

Design, Setting, And Participants: Following the methodology framework and analytical strategies used in the 2016 Global Burden of Disease study, the mortality, prevalence, and disability-adjusted life-years (DALYs) of CVD in the Chinese population were examined by age, sex, and year and according to 10 subcategories. Estimates were produced for all province-level administrative units of mainland China, Hong Kong, and Macao.

Exposures: Residence in China.

Main Outcomes And Measures: Mortality, prevalence, and DALYs of CVD.

Results: The annual number of deaths owing to CVD increased from 2.51 million to 3.97 million between 1990 and 2016; the age-standardized mortality rate fell by 28.7%, from 431.6 per 100 000 persons in 1990 to 307.9 per 100 000 in 2016. Prevalent cases of CVD doubled since 1990, reaching nearly 94 million in 2016. The age-standardized prevalence rate of CVD overall increased significantly from 1990 to 2016 by 14.7%, as did rates for ischemic heart disease (19.1%), ischemic stroke (36.6%), cardiomyopathy and myocarditis (23.1%), and endocarditis (26.7%). Substantial reduction in the CVD burden, as measured by age-standardized DALY rate, was observed from 1990 to 2016 nationally, with a greater reduction in women (43.7%) than men (24.7%). There were marked differences in the spatial patterns of mortality, prevalence, and DALYs of CVD overall as well as its main subcategories, including ischemic heart disease, hemorrhagic stroke, and ischemic stroke. The CVD burden appeared to be lower in coastal provinces with higher economic development. The between-province gap in relative burden of CVD increased from 1990 to 2016, with faster decline in economically developed provinces.

Conclusions And Relevance: Substantial discrepancies in the total CVD burden and burdens of CVD subcategories have persisted between provinces in China despite a relative decrease in the CVD burden. Geographically targeted considerations are needed to tailor future strategies to enhance CVD health throughout China and in specific provinces.

Citing Articles

Development and validation of a risk score for predicting 30-day mortality in patients with ST elevation myocardial infarction.

Wang S, Zhang Y, Qi D, Wang X, Zhu Z, Yang W Sci Rep. 2025; 15(1):8930.

PMID: 40087520 DOI: 10.1038/s41598-025-92615-3.


Longitudinal association of urinary DHPPA and DHBA with cardiometabolic risk markers in Chinese community-dwelling adults.

Shao Y, Sun Z, Yin K, Xu M, Zhao J, Zhang Z Eur J Nutr. 2025; 64(3):112.

PMID: 40053167 DOI: 10.1007/s00394-025-03637-6.


Unveiling China's heart disease challenges: a comprehensive retrospective study on national mortality burden.

Yang Y, Min J, Zha Y BMC Public Health. 2025; 25(1):862.

PMID: 40038636 PMC: 11877749. DOI: 10.1186/s12889-025-21710-x.


Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects.

Ru Q, Li Y, Zhang X, Chen L, Wu Y, Min J Bone Res. 2025; 13(1):27.

PMID: 40000618 PMC: 11861620. DOI: 10.1038/s41413-024-00398-6.


Unlocking the link: predicting cardiovascular disease risk with a focus on airflow obstruction using machine learning.

Cao X, Ma J, He X, Liu Y, Yang Y, Wang Y BMC Med Inform Decis Mak. 2025; 25(1):50.

PMID: 39901185 PMC: 11792416. DOI: 10.1186/s12911-025-02885-0.


References
1.
Wei Y, Hu D, Zhang R, Zheng L, Li J, Yu J . [Metabolic syndrome complicated by peripheral arterial disease: clinical study of 2115 cases]. Zhonghua Yi Xue Za Zhi. 2006; 86(30):2114-6. View

2.
. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1345-1422. PMC: 5614451. DOI: 10.1016/S0140-6736(17)32366-8. View

3.
Bi Y, Gao R, Patel A, Su S, Gao W, Hu D . Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. Am Heart J. 2009; 157(3):509-516.e1. DOI: 10.1016/j.ahj.2008.09.026. View

4.
Zhang L, Yang J, Hong Z, Yuan G, Zhou B, Zhao L . Proportion of different subtypes of stroke in China. Stroke. 2003; 34(9):2091-6. DOI: 10.1161/01.STR.0000087149.42294.8C. View

5.
Wang W, Wang D, Liu H, Sun H, Jiang B, Ru X . Trend of declining stroke mortality in China: reasons and analysis. Stroke Vasc Neurol. 2017; 2(3):132-139. PMC: 5628381. DOI: 10.1136/svn-2017-000098. View